Similar articles

• Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.

  Otterstad JE, St John Sutton MG, Froeland GS, Holme I, Skjaerpe T, Hall C. Otterstad JE, et al. Eur Heart J. 2002 Jul;23(13):1011-20. doi: 10.1053/euhj.2001.2969. Eur Heart J. 2002. PMID: 12093053
• Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.

  Svanegaard J, Johansen JB, Klitgaard NA, Thayssen P, Haghfelt T. Svanegaard J, et al. Scand Cardiovasc J. 1999;33(6):355-61. doi: 10.1080/14017439950141425. Scand Cardiovasc J. 1999. PMID: 10622548
• N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease.

  Hall C, Ihlen H, Bonarjee V, Dickstein K, Kjekshus J. Hall C, et al. Int J Cardiol. 2003 Jun;89(2-3):197-205. doi: 10.1016/s0167-5273(02)00479-5. Int J Cardiol. 2003. PMID: 12767543
• N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.

  Hole T, Hall C, Skaerpe T. Hole T, et al. Eur Heart J. 2004 Mar;25(5):416-23. doi: 10.1016/j.ehj.2003.10.036. Eur Heart J. 2004. PMID: 15033254 Clinical Trial.
• Brain natriuretic peptide and acute coronary syndrome.

  Mazzone M, Forte P, Portale G, Mancini F, Ursella S, La Sala M, Testa A, Covino M, Pignataro G, Gentiloni Silveri N. Mazzone M, et al. Minerva Med. 2005 Feb;96(1):11-8. Minerva Med. 2005. PMID: 15827538 Review.